US$ 26.89
semaglutide regulations π¨ FDA Ends Shortage The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant Orbicular Receives Health Canada Approval
Description
Sources: Novo Nordisk
M.SmitJ

Raman and Texas Star Pharmacy were given a $1,000 penalty each as a sanction from the Texas State Board of Pharmacy for having dispensed and shipped prescriptions into a state where the pharmacy was not licensed to operate. The violation says that the pharmacy dispensed and sold 19 prescriptions to 19 patients in North Dakota, where the pharmacy was not licensed

doi:10.1126/scitranslmed.aar7047 47
Wegovy steps into the arena by not only promoting a more efficient calorie burn through boosted metabolism but also supporting comprehensive weight loss
